Cocrystal Pharma, Inc. (DUS:8CC) Financings

Cocrystal Pharma, Inc.

Financings

RaiseDate
Private placement of common stock
Closed: US$5M raised · US$0.9134 a share
Buyers: OPKO (5,474,053 shares of common stock for $5.0 million)
Aug 3, 2026
Private placement of units of common stock and unregistered warrants
Closed: US$1.03M raised · US$1.39 a unit · Warrants at US$1.24 for 27 months
Buyers: Phillip Frost, M.D.; Fred Hassan; Richard Pfenniger; James Martin
Insiders: All four investors are insiders: directors Phillip Frost, Fred Hassan and Richard Pfenniger, and co-CEO and CFO James Martin
Use of proceeds: Support clinical development programs, working capital and general corporate purposes
Oct 30, 2025
Registered direct offering of shares of common stock with unregistered warrants
Closed: US$4.7M raised · US$1.7 a share · Warrants at US$1.5 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Sep 15, 2025

Read by 6ix AI from the company's releases